Subscribe to Newsletter

November 2019 Issue of The Medicine Maker

In the second issue of The Small Molecule Manufacturer, find out how continuous manufacturing is evolving in the pharma industry with advances in equipment, processes and facilities as more companies make the switch from batch. In The Next Big Thing, we also dive into the future of API synthesis with AI and protein engineering, while Inside The Medicine Machine offers a peak into the world of pharmaceutical mixing. Also included in the issue, Upfront provides a snapshot of the global market forecast for excipients, a round up of the latest industry business news, and an interview about how capsules inspired an art competition. Finally, we sit down with Chip Davis, President and CEO of the Association for Accessible Medicines.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Manufacture Small Molecules

Bang the Drum

| Stephanie Vine

Pharma companies have been raising awareness for years, but patients continue to buy counterfeit medicines online.
Business & Regulation Business Practice

Role Call

Here, we speak with Matthew Moorcroft, Vice President of Marketing & Intelligence at Cambrex.
Business & Regulation Trends & Forecasts

A Forecast for Excipients

A snapshot of the global market forecast for the pharmaceutical excipients market.

Manufacture Small Molecules

Continuous in the Spotlight

| Stephanie Vine, Maryam Mahdi

Continuus was established with the primary objective of shining a spotlight on continuous manufacturing.
Manufacture Technology and Equipment

Eyes on Continuous Equipment

| Richard Steiner

What innovations are enabling a changeover to continuous?
Manufacture Technology and Equipment

To Be Continued

Hovione’s New Jersey-based site has provided process development and small volume API manufacturing since 2002.

Manufacture Small Molecules

The Devil's in the Details

| Marcial Gonzalez, Dale Natoli

The reported benefits of continuous manufacturing for small molecules over batch manufacturing include accelerated product and process development.
Manufacture Technology and Equipment

Updating the Toolbox

| Jonathan Knight, Shawn Conway

The economic and technological advantages of continuous flow chemistry are driving adoption by API manufacturers.
Manufacture Small Molecules

Mixing It Up

Denis Hunn from ystral takes us inside the world of the mixer, highlighting how technologies have changed over the years.
Manufacture Small Molecules

The Future of API Synthesis

| David Entwistle, Oscar Alvizo

We need to produce molecules faster, more economically and with greater control.
Manufacture Business Practice

The Importance of Access

Sitting Down With... Chip Davis, President and CEO of the Association for Accessible Medicines (AAM).

Other issues of 2019